Clinical Pharmacogenomics Group
The Clinical Pharmacogenomics Group aims to personalise medicine by studying DNA variations to better target a drug, or its dose, to improve health and prevent toxic reactions.
Pharmacogenomics is the study of variations in our genome (DNA and RNA) that alter our response to medicines and contribute to adverse drug reactions, and also how these genetic variations can be translated into clinical practice to provide a ‘precision medicine’ approach.
The Clinical Pharmacogenomics Group investigates genetic variants that impact on drug responses and a person’s immune response to drugs. We use various approaches, including pharmacokinetics, metabolism, pharmacodynamics (such as receptors and signalling messengers) and immune markers of drug hypersensitivity reactions.
Our studies look at drug metabolism and response (across cancer, addiction, solid-organ transplantation outcomes, depression), infectious diseases in Papua New Guinea (HIV, Tuberculosis), neurogastroenterology and molecular toxicity (via a chemotherapy-induced model of mucositis), pain (such as persistent post-surgical pain, chronic pain in spinal cord injury and fibromyalgia, palliative medicine), gulf-war illness and epilepsy, and drug abuse and addiction.
Our large research program investigates pharmacogenomics of Aboriginal Australians. Discovery of interethnic differences in drug response and the genetic factors that contribute to such differences are of importance for drug and dosing guidelines.
Professor Andrew Somogyi
Professor Andrew Somogyi is a Professor of Clinical and Experimental Pharmacology and practicing pharmacist. He teaches pharmacology in undergraduate medicine, dentistry, nursing and health science programs and has a PhD from the University of Sydney, School of Pharmacy.
In 2010 Professor Somogyi was made an Honorary Fellow of the Faculty of Pain Medicine in the Australian and New Zealand College of Anaesthetists and in 2016 a Fellow of the British Pharmacological Society.
Partner Institution/Organisation Professor Lisa Jamieson Adelaide Dental School, University of Adelaide Professor Pal Klepstad Norwegian University of Science and Technology, Trondheim, Norway Associate Professor Michal Kluger University of New Zealand Professor Colleen Loo University of New South Wales Associate Professor Paul Pumuye University of Papua New Guinea Professor Alex Sia KK Women’s and Children’s Hospital, Singapore Professor Jennifer Philip St Vincent’s Hospital, Melbourne Dr Peter Poon Monash Health and Monash University Dr Chris Davey University of Melbourne
Related areas of research
We offer exciting opportunities for researchers at the honours, masters and PhD levels. Our research degrees are open to students from a broad range of backgrounds, and range from basic sciences to clinical research. If you are interested in human health, consider furthering your research career with us.